Cargando…

Clinical course & management of childhood nephrotic syndrome in Germany: a large epidemiological ESPED study

BACKGROUND: Nephrotic syndrome (NS) is one of the most frequent occurring chronic kidney diseases in childhood, despite its rarely occurrence in the general population. Detailed information about clinical data of NS (e.g. average length of stay, complications) as well as of secondary nephrotic syndr...

Descripción completa

Detalles Bibliográficos
Autores principales: Franke, Ingo, Aydin, Malik, Kurylowicz, Lisa, Lopez, Corinna Elke Llamas, Ganschow, Rainer, Lentze, Michael J., Born, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367765/
https://www.ncbi.nlm.nih.gov/pubmed/30732569
http://dx.doi.org/10.1186/s12882-019-1233-1
_version_ 1783393866983931904
author Franke, Ingo
Aydin, Malik
Kurylowicz, Lisa
Lopez, Corinna Elke Llamas
Ganschow, Rainer
Lentze, Michael J.
Born, Mark
author_facet Franke, Ingo
Aydin, Malik
Kurylowicz, Lisa
Lopez, Corinna Elke Llamas
Ganschow, Rainer
Lentze, Michael J.
Born, Mark
author_sort Franke, Ingo
collection PubMed
description BACKGROUND: Nephrotic syndrome (NS) is one of the most frequent occurring chronic kidney diseases in childhood, despite its rarely occurrence in the general population. Detailed information about clinical data of NS (e.g. average length of stay, complications) as well as of secondary nephrotic syndrome (SNS) is not well known. METHODS: A nationwide ESPED follow-up study presenting the clinical course and management of children with NS in Germany. RESULTS: In course of 2 years, 347 children developed the first onset of NS, hereof 326 patients (93.9%) had a primary NS, and 19 patients had a SNS (missing data in 2 cases), the majority due to a Henoch-Schönlein Purpura. Patients with steroid-resistant NS (SRNS) stayed significantly longer in hospital than children with steroid-sensitive NS (25.2 vs. 13.3 d, p <  0.001). Patients with bacterial/viral infections stayed longer in hospital (24.9 d/19.5d) than children without an infection (14.2 d/14.9 d; p <  0.001; p = 0.016). Additionally, children with urinary tract infections (UTI) (p < 0,001), arterial hypertension (AH) (p < 0.001) and acute renal failure (ARF) (p < 0,001) stayed significantly longer in hospital. Patients with SRNS had frequent complications (p = 0.004), such as bacterial infections (p = 0.013), AH (p < 0.001), UTI (p < 0.001) and ARF (p = 0.007). Children with a focal segmental glomerulosclerosis (FSGS) had significantly more complications (p = 0.04); specifically bacterial infections (p = 0.01), UTI (p = 0.003) and AH (p < 0,001). Steroid-resistance was more common in patients with UTI (p < 0.001) and in patients with ARF (p = 0.007). Furthermore, steroid-resistance (p < 0.001) and FSGS (p < 0.001) were more common in patients with AH. CONCLUSIONS: This nationwide, largest German study presents results on the clinical course of children with NS considering a diverse range of complications that can occur with NS. The establishment of a region-wide and international pediatric NS register would be useful to conduct further diagnostic and therapy studies with the aim to reduce the complication rate and to improve the prognosis of NS, and to compare the data with international cohorts. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12882-019-1233-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6367765
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63677652019-02-15 Clinical course & management of childhood nephrotic syndrome in Germany: a large epidemiological ESPED study Franke, Ingo Aydin, Malik Kurylowicz, Lisa Lopez, Corinna Elke Llamas Ganschow, Rainer Lentze, Michael J. Born, Mark BMC Nephrol Research Article BACKGROUND: Nephrotic syndrome (NS) is one of the most frequent occurring chronic kidney diseases in childhood, despite its rarely occurrence in the general population. Detailed information about clinical data of NS (e.g. average length of stay, complications) as well as of secondary nephrotic syndrome (SNS) is not well known. METHODS: A nationwide ESPED follow-up study presenting the clinical course and management of children with NS in Germany. RESULTS: In course of 2 years, 347 children developed the first onset of NS, hereof 326 patients (93.9%) had a primary NS, and 19 patients had a SNS (missing data in 2 cases), the majority due to a Henoch-Schönlein Purpura. Patients with steroid-resistant NS (SRNS) stayed significantly longer in hospital than children with steroid-sensitive NS (25.2 vs. 13.3 d, p <  0.001). Patients with bacterial/viral infections stayed longer in hospital (24.9 d/19.5d) than children without an infection (14.2 d/14.9 d; p <  0.001; p = 0.016). Additionally, children with urinary tract infections (UTI) (p < 0,001), arterial hypertension (AH) (p < 0.001) and acute renal failure (ARF) (p < 0,001) stayed significantly longer in hospital. Patients with SRNS had frequent complications (p = 0.004), such as bacterial infections (p = 0.013), AH (p < 0.001), UTI (p < 0.001) and ARF (p = 0.007). Children with a focal segmental glomerulosclerosis (FSGS) had significantly more complications (p = 0.04); specifically bacterial infections (p = 0.01), UTI (p = 0.003) and AH (p < 0,001). Steroid-resistance was more common in patients with UTI (p < 0.001) and in patients with ARF (p = 0.007). Furthermore, steroid-resistance (p < 0.001) and FSGS (p < 0.001) were more common in patients with AH. CONCLUSIONS: This nationwide, largest German study presents results on the clinical course of children with NS considering a diverse range of complications that can occur with NS. The establishment of a region-wide and international pediatric NS register would be useful to conduct further diagnostic and therapy studies with the aim to reduce the complication rate and to improve the prognosis of NS, and to compare the data with international cohorts. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12882-019-1233-1) contains supplementary material, which is available to authorized users. BioMed Central 2019-02-07 /pmc/articles/PMC6367765/ /pubmed/30732569 http://dx.doi.org/10.1186/s12882-019-1233-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Franke, Ingo
Aydin, Malik
Kurylowicz, Lisa
Lopez, Corinna Elke Llamas
Ganschow, Rainer
Lentze, Michael J.
Born, Mark
Clinical course & management of childhood nephrotic syndrome in Germany: a large epidemiological ESPED study
title Clinical course & management of childhood nephrotic syndrome in Germany: a large epidemiological ESPED study
title_full Clinical course & management of childhood nephrotic syndrome in Germany: a large epidemiological ESPED study
title_fullStr Clinical course & management of childhood nephrotic syndrome in Germany: a large epidemiological ESPED study
title_full_unstemmed Clinical course & management of childhood nephrotic syndrome in Germany: a large epidemiological ESPED study
title_short Clinical course & management of childhood nephrotic syndrome in Germany: a large epidemiological ESPED study
title_sort clinical course & management of childhood nephrotic syndrome in germany: a large epidemiological esped study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367765/
https://www.ncbi.nlm.nih.gov/pubmed/30732569
http://dx.doi.org/10.1186/s12882-019-1233-1
work_keys_str_mv AT frankeingo clinicalcoursemanagementofchildhoodnephroticsyndromeingermanyalargeepidemiologicalespedstudy
AT aydinmalik clinicalcoursemanagementofchildhoodnephroticsyndromeingermanyalargeepidemiologicalespedstudy
AT kurylowiczlisa clinicalcoursemanagementofchildhoodnephroticsyndromeingermanyalargeepidemiologicalespedstudy
AT lopezcorinnaelkellamas clinicalcoursemanagementofchildhoodnephroticsyndromeingermanyalargeepidemiologicalespedstudy
AT ganschowrainer clinicalcoursemanagementofchildhoodnephroticsyndromeingermanyalargeepidemiologicalespedstudy
AT lentzemichaelj clinicalcoursemanagementofchildhoodnephroticsyndromeingermanyalargeepidemiologicalespedstudy
AT bornmark clinicalcoursemanagementofchildhoodnephroticsyndromeingermanyalargeepidemiologicalespedstudy